Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Lijun Deng was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • Mar 30
Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Duyuru • Dec 26
Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026 Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026 Duyuru • Sep 30
Dawei Technology (Guangdong) Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Duyuru • Jun 30
Dawei Technology (Guangdong) Group Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Duyuru • Mar 28
Dawei Technology (Guangdong) Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Duyuru • Mar 19
Dawei Technology (Guangdong) Group Co., Ltd., Annual General Meeting, Apr 08, 2025 Dawei Technology (Guangdong) Group Co., Ltd., Annual General Meeting, Apr 08, 2025, at 15:00 China Standard Time. Location: 13F, Tower B, 33 Building, Xiaoyun Road, Maizidian Subdistrict, Chaoyang District, Beijing China Duyuru • Dec 27
Dawei Technology (Guangdong) Group Co., Ltd. to Report Fiscal Year 2024 Results on Mar 19, 2025 Dawei Technology (Guangdong) Group Co., Ltd. announced that they will report fiscal year 2024 results on Mar 19, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.005 (vs CN¥0.061 loss in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.005 (up from CN¥0.061 loss in 3Q 2023). Revenue: CN¥101.2m (up 8.1% from 3Q 2023). Net income: CN¥9.55m (up CN¥52.5m from 3Q 2023). Profit margin: 9.4% (up from net loss in 3Q 2023). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 24
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥3.70, the stock trades at a trailing P/E ratio of 44.2x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years. Duyuru • Sep 30
Guangdong Rongtai Industry Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024 Guangdong Rongtai Industry Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024 Valuation Update With 7 Day Price Move • Sep 21
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥2.55, the stock trades at a trailing P/E ratio of 30.4x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years. New Risk • Sep 14
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Large one-off items impacting financial results. Reported Earnings • Aug 23
Second quarter 2024 earnings released: CN¥0.039 loss per share (vs CN¥0.053 loss in 2Q 2023) Second quarter 2024 results: CN¥0.039 loss per share. Revenue: CN¥106.6m (up 13% from 2Q 2023). Net loss: CN¥41.6m (loss widened 12% from 2Q 2023). New Risk • Jul 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change). Duyuru • Jun 28
Guangdong Rongtai Industry Co.,Ltd to Report First Half, 2024 Results on Aug 23, 2024 Guangdong Rongtai Industry Co.,Ltd announced that they will report first half, 2024 results on Aug 23, 2024 Valuation Update With 7 Day Price Move • Jun 25
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥3.14, the stock trades at a trailing P/E ratio of 36.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥3.99, the stock trades at a trailing P/E ratio of 46x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 107% over the past three years. Board Change • May 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Supervisor Weibin Xu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥4.00, the stock trades at a trailing P/E ratio of 71.6x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years. Duyuru • Mar 29
Guangdong Rongtai Industry Co.,Ltd to Report Q1, 2024 Results on Apr 26, 2024 Guangdong Rongtai Industry Co.,Ltd announced that they will report Q1, 2024 results on Apr 26, 2024 Duyuru • Mar 19
Guangdong Rongtai Industry Co.,Ltd, Annual General Meeting, Apr 08, 2024 Guangdong Rongtai Industry Co.,Ltd, Annual General Meeting, Apr 08, 2024, at 15:00 China Standard Time. Location: 13F, Tower B, No. 33, Xiaoyun Road, Chaoyang District, Beijing China Reported Earnings • Mar 19
Full year 2023 earnings released: EPS: CN¥0.06 (vs CN¥1.06 loss in FY 2022) Full year 2023 results: EPS: CN¥0.06 (up from CN¥1.06 loss in FY 2022). Revenue: CN¥366.8m (down 13% from FY 2022). Net income: CN¥82.6m (up CN¥828.0m from FY 2022). Profit margin: 23% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. New Risk • Jan 09
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 110% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥200m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-CN¥791m). Earnings have declined by 29% per year over the past 5 years. Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Duyuru • Dec 30
Guangdong Rongtai Industry Co.,Ltd to Report Fiscal Year 2023 Results on Mar 22, 2024 Guangdong Rongtai Industry Co.,Ltd announced that they will report fiscal year 2023 results on Mar 22, 2024 Duyuru • Sep 30
Guangdong Rongtai Industry Co.,Ltd to Report Q3, 2023 Results on Oct 28, 2023 Guangdong Rongtai Industry Co.,Ltd announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023 Board Change • Sep 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Director Xiaoxuan Liu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. New Risk • Aug 25
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥279m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥279m free cash flow). Share price has been highly volatile over the past 3 months (8.4% average weekly change). Negative equity (-CN¥748m). Earnings have declined by 35% per year over the past 5 years. New Risk • Aug 10
New major risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CN¥711m). Earnings have declined by 40% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change). Reported Earnings • Apr 26
Full year 2022 earnings released: CN¥1.06 loss per share (vs CN¥1.01 loss in FY 2021) Full year 2022 results: CN¥1.06 loss per share (further deteriorated from CN¥1.01 loss in FY 2021). Revenue: CN¥421.1m (down 46% from FY 2021). Net loss: CN¥745.4m (loss widened 5.1% from FY 2021). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 27
Third quarter 2022 earnings released: CN¥0.003 loss per share (vs CN¥0.053 loss in 3Q 2021) Third quarter 2022 results: CN¥0.003 loss per share (improved from CN¥0.053 loss in 3Q 2021). Net loss: CN¥2.05m (loss narrowed 95% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings. Reported Earnings • Aug 27
Second quarter 2022 earnings released: CN¥0.046 loss per share (vs CN¥0.025 profit in 2Q 2021) Second quarter 2022 results: CN¥0.046 loss per share (down from CN¥0.025 profit in 2Q 2021). Revenue: CN¥119.3m (down 58% from 2Q 2021). Net loss: CN¥31.2m (down 278% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings. Reported Earnings • May 02
First quarter 2022 earnings released: CN¥0.019 loss per share (vs CN¥0.018 loss in 1Q 2021) First quarter 2022 results: CN¥0.019 loss per share (down from CN¥0.018 loss in 1Q 2021). Revenue: CN¥198.6m (down 28% from 1Q 2021). Net loss: CN¥13.6m (loss widened 8.3% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Reported Earnings • Oct 31
Third quarter 2021 earnings released: CN¥0.053 loss per share (vs CN¥0.002 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥236.7m (down 9.6% from 3Q 2020). Net loss: CN¥37.3m (down CN¥38.6m from profit in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 28
Second quarter 2021 earnings released: EPS CN¥0.025 (vs CN¥0.012 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥284.9m (up 14% from 2Q 2020). Net income: CN¥17.5m (up 106% from 2Q 2020). Profit margin: 6.1% (up from 3.4% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance. Reported Earnings • May 03
Full year 2020 earnings released: CN¥1.73 loss per share (vs CN¥0.76 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: CN¥1.07b (down 27% from FY 2019). Net loss: CN¥1.22b (loss widened 126% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Jan 25
New 90-day low: CN¥2.82 The company is down 27% from its price of CN¥3.84 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period. Is New 90 Day High Low • Jan 06
New 90-day low: CN¥3.18 The company is down 22% from its price of CN¥4.08 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Dec 14
New 90-day low: CN¥3.49 The company is down 19% from its price of CN¥4.31 on 16 September 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total losses of CN¥831.7m, with earnings decreasing by CN¥1.17b from the prior year. Total revenue was CN¥1.14b over the last 12 months, down 27% from the prior year. Is New 90 Day High Low • Oct 29
New 90-day low: CN¥3.80 The company is down 13% from its price of CN¥4.36 on 31 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period. Is New 90 Day High Low • Sep 28
New 90-day low: CN¥3.94 The company is down 8.0% from its price of CN¥4.28 on 30 June 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. 